SEC Lawsuit Against SolarWinds Survives Motion to Dismiss—but Barely

A federal court has dismissed most of the SEC’s complaint against software company SolarWinds for alleged securities laws violations related to the SUNBURST cyberattack. A sliver of the SEC’s case against SolarWinds and its CISO Timothy Brown survives: the allegations regarding misstatements in the company’s public Security Statement. Now, the SEC will have the opportunity […]

Read More
Dialysis Kickback Settlement in the News

Our client’s False Claims Act case against international dialysis company DaVita, which settled last week for $34.5 million, has been featured in numerous articles. The various press reports highlighted different aspects of this complex antikickback case. Law360 quoted Whistleblower Partners attorneys Mike Ronickher and Hamsa Mahendranathan on why the kickback law exists, the financial incentives […]

Read More
Whistleblower Partners Client Receives Relator’s Share Awards in Kickback Cases Against DaVita

Whistleblower Partners is proud to announce that the United States has settled our client’s False Claims Act case against international dialysis company DaVita for $34.5 million. The covered conduct concerns allegations of three novel kickback theories involving DaVita’s pharmacy business, its vascular access center business, and medical directorships at dialysis centers. After intervening and settling […]

Read More
Rite Aid Settles Two Large False Claims Act Cases, Showing How Whistleblowers Can Combat the Opioid Crisis and Fight Medicare Fraud

Last week, Rite Aid, America’s third largest retail pharmacy after CVS and Walgreens, settled two massive whistleblower cases, agreeing to pay potentially upwards of $500 million to resolve disparate allegations of healthcare fraud. The Opioid Dispensing Settlement: Last Wednesday, the Department of Justice announce that Rite Aid will pay up to roughly $410 million to […]

Read More
Government to Target Peripheral Vascular Procedures

Medicare spending on a subset of cardio procedures has skyrocketed and the Office of Inspector General (OIG) has taken note, apparently now on the hunt for fraudsters. Certain minimally invasive peripheral vascular procedures, such as atherectomies and angioplasties, are meant to alleviate blockages and improve blood flow when arteries are narrowed due to peripheral arterial […]

Read More
IRS Program Continues to Show Improvement

The 2023 Annual Report from the IRS Whistleblower Office, while not breathless reading, has evolved from a short, dry affair, to a nicely organized and, more importantly, significantly more informative document. Even better? The report includes some real bright spots for the program that show that it is continuing to improve and grow toward its […]

Read More
Whistleblower Partners Attorney Chris McLamb Recognized in “Lawdragon 500 X – The Next Generation” Guide

We are pleased to announce that Lawdragon has named Chris McLamb to its 2024 “Lawdragon 500 X – The Next Generation” guide, which is designed to identify “the future leaders of the law.” Chris is a Partner in our Washington, DC office. Lawdragon is a leading publisher of “best lawyer” guides recognizing the most effective […]

Read More
Risk Adjustment Fraud is Picking Medicare’s Pockets

There is no bigger target for fraud than the Medicare Advantage program, which insures over half of Medicare-eligible beneficiaries. The New York Times reports that “Most large insurers in the program have been accused in court of fraud.” Understaffed government auditors cannot keep up. Not satisfied with the unlevel playing field, however, one of the […]

Read More
Cybersecurity Whistleblowers Turn Up the Heat on Microsoft and Guidehouse

Whistleblower watchdogs have proven to be essential in aiding the Government’s efforts to protect the public against cybersecurity breaches and vulnerabilities, as evidenced by two recent stories making news headlines.  First, whistleblower Elevation 33, LLC, an entity owned by a former Guidehouse employee, helped DOJ secure an $11.5M settlement, one of the largest cybersecurity settlements […]

Read More
The FCA: A Tool Healthcare Industry Plaintiffs Shouldn’t Ignore

A recent Federal court decision coming out of New Jersey demonstrates the viability of an unusual kind of whistleblower, a privately defrauded party. The most common protype of a whistleblower under the False Claims Act (FCA) is a corporate insider who sees fraud against the government at their employer or a company they work with […]

Read More